<DOC>
	<DOCNO>NCT00001668</DOCNO>
	<brief_summary>The von Hippel Lindau ( VHL ) gene recently identify genetic defect result syndrome multiple neoplasia . Patients VHL disease develop retinal angioma , renal cyst and/or carcinoma , CNS hemangioblastomas well pancreatic cyst pheochromocytomas . Investigators show gene tumor suppressor type proto-oncogene locate chromosomal locus 3p26 . The gene include three exon whose gene product target cellular transcription factor Elongin SIII . Binding VHL proteins two subunit elongation factor inhibits transcription may play crucial role clinical development von Hippel Lindau phenotype .</brief_summary>
	<brief_title>Endolymphatic Sac Tumors Population Patients With Von Hippel-Lindau Disease : The Natural History Pathobiology , Prospective Non-Randomized Clinical Trial Hearing Preservation Surgery Patients With Early Stage Endolymphatic Sac Tumors</brief_title>
	<detailed_description>The von Hippel Lindau ( VHL ) gene recently identify genetic defect result syndrome multiple neoplasia . Patients VHL disease develop retinal angioma , renal cyst and/or carcinoma , CNS hemangioblastomas well pancreatic cyst pheochromocytomas . Investigators show gene tumor suppressor type proto-oncogene locate chromosomal locus 3p26 . The gene include three exon whose gene product target cellular transcription factor Elongin SIII . Binding VHL proteins two subunit elongation factor inhibits transcription may play crucial role clinical development von Hippel Lindau phenotype .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Von Hippel-Lindau Disease</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>Patients meet diagnostic criterion von HippelLindau ( VHL ) disease . No person pregnant lactate eligible surgical arm protocol pregnancy and/or nursing period reach completion . No patient disorder associated multiple abnormality middle ear inner ear . Specific laboratory abnormality antiHIV1 , FTAAbs , serum ANA , ANCA associate AIDS , Syphilis , Systemic Lupus Erythematosus , Wegener 's Granulomatosis , respectively . No patient currently undergo chemotherapeutic regimen ototoxic agent ( e.g. , cisplatin ) . Other agent review casebycase basis potential cause ototoxicity thereby interfere audiologic data interpretation . Patients ELST hear ear exclude protocol surgical treatment ELST 's ( except case medical indication necessitate intervention welfare patient ) . Patients unilateral vestibular function side affect ELST , document caloric ENG testing , exclude surgical treatment group case . No patient inability understand requirement study inability give inform consent and/or comply aspects evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1999</verification_date>
	<keyword>Deafness</keyword>
	<keyword>Hemangioblastoma</keyword>
	<keyword>Papillary Carcinoma</keyword>
	<keyword>VHL Gene</keyword>
	<keyword>Vestibular Function</keyword>
	<keyword>von Hippel-Lindau Disease</keyword>
</DOC>